Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law.
In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society.
In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society.
Price: $87.00
Pages: 312
Publisher: Brill
Imprint: Brill | Nijhoff
Publication Date:
09 March 2023
ISBN: 9789004526082
Format: Paperback
Santa Slokenberga, LL.D., is a senior lecturer in Administrative Law at Uppsala University. Santa’s research focuses on the regulation of new health technologies and the protection of personal data. Her other research interests include child’s rights in biomedicine.
Timo Minssen is Professor of Law at the University of Copenhagen and the Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research and advisory practice concentrates on Intellectual Property, Competition, Data Protection & Regulatory Law with a special focus on new technologies in the health & life sciences.
Ana Nordberg is associate professor and senior lecturer in Civil/Private Law at Lund University, Sweden. Specialised in Intellectual property and data issues, her research can be described as focusing on the intersection(s) between law and technology, with a special emphasis on the health and wellness sector.
Timo Minssen is Professor of Law at the University of Copenhagen and the Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research and advisory practice concentrates on Intellectual Property, Competition, Data Protection & Regulatory Law with a special focus on new technologies in the health & life sciences.
Ana Nordberg is associate professor and senior lecturer in Civil/Private Law at Lund University, Sweden. Specialised in Intellectual property and data issues, her research can be described as focusing on the intersection(s) between law and technology, with a special emphasis on the health and wellness sector.